1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66E167BB047793CC300258A38003B1B51
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/6E167BB047793CC300258A38003B1B51?OpenDocument
18
19OpenDocument
203.236.142.143
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Field Medical Excellence

Document Excerpt: Rare Blood Disorders MSL Team Excellence: Benchmarking Recruitment, Retention, and Compensation Levels

DB Image

ID: MD-880


Features:

14 Info Graphics

8 Data Graphics

120+ Metrics

61 Narratives


Pages/Slides: 4


Published: 2023


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5780 “Rare Blood Disorders MSL Team Excellence: Benchmarking Recruitment, Retention, and Compensation Levels”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care


Companies Profiled:
Agios; Alexion Pharmaceuticals; Apellis Pharmaceuticals; Astellas; Bayer; BioMarin; Chiesi; CSL Behring; Fresenius Medical Care; Kyowa Kirin; Legend Biotech; Novartis; Novo Nordisk; Servier; Sobi; Takeda Pharmaceuticals; Vertex Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.